CN110063916A - 可淡化黑眼圈、祛眼袋和眼纹的组合物 - Google Patents
可淡化黑眼圈、祛眼袋和眼纹的组合物 Download PDFInfo
- Publication number
- CN110063916A CN110063916A CN201910449400.3A CN201910449400A CN110063916A CN 110063916 A CN110063916 A CN 110063916A CN 201910449400 A CN201910449400 A CN 201910449400A CN 110063916 A CN110063916 A CN 110063916A
- Authority
- CN
- China
- Prior art keywords
- eye
- composition
- vitamin
- preservative
- eyeprint
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 24
- 229930003448 Vitamin K Natural products 0.000 title claims abstract description 21
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 title claims abstract description 21
- 235000019168 vitamin K Nutrition 0.000 title claims abstract description 21
- 239000011712 vitamin K Substances 0.000 title claims abstract description 21
- 150000003721 vitamin K derivatives Chemical class 0.000 title claims abstract description 21
- 229940046010 vitamin k Drugs 0.000 title claims abstract description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 33
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000003755 preservative agent Substances 0.000 claims abstract description 19
- 230000002335 preservative effect Effects 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 14
- 229960000458 allantoin Drugs 0.000 claims abstract description 14
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 14
- XNLFHCPVTULKIV-VAWYXSNFSA-N (e)-3-(4-methylphenyl)-1-phenylprop-2-en-1-one Chemical compound C1=CC(C)=CC=C1\C=C\C(=O)C1=CC=CC=C1 XNLFHCPVTULKIV-VAWYXSNFSA-N 0.000 claims abstract description 13
- 241000208690 Hamamelis Species 0.000 claims abstract description 13
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 claims abstract description 13
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 12
- 239000012153 distilled water Substances 0.000 claims abstract description 12
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 12
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 12
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims abstract description 11
- 235000002906 tartaric acid Nutrition 0.000 claims abstract description 11
- 239000011975 tartaric acid Substances 0.000 claims abstract description 11
- 239000002738 chelating agent Substances 0.000 claims abstract description 10
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 claims abstract description 9
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 claims abstract description 9
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical group [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 claims description 7
- 239000006071 cream Substances 0.000 claims description 6
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical group OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 claims description 5
- 229960003993 chlorphenesin Drugs 0.000 claims description 5
- 230000001815 facial effect Effects 0.000 claims description 4
- 239000000654 additive Substances 0.000 claims description 3
- 230000000996 additive effect Effects 0.000 claims description 3
- 210000001643 allantois Anatomy 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 235000013336 milk Nutrition 0.000 claims description 2
- 239000008267 milk Substances 0.000 claims description 2
- 210000004080 milk Anatomy 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 2
- 150000001336 alkenes Chemical class 0.000 claims 1
- YAVVGPBYBUYPSR-UHFFFAOYSA-N benzene;oxygen Chemical compound [O].C1=CC=CC=C1 YAVVGPBYBUYPSR-UHFFFAOYSA-N 0.000 claims 1
- 235000019441 ethanol Nutrition 0.000 claims 1
- 229930182470 glycoside Natural products 0.000 claims 1
- 150000002338 glycosides Chemical class 0.000 claims 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 abstract description 11
- 102000008186 Collagen Human genes 0.000 abstract description 2
- 108010035532 Collagen Proteins 0.000 abstract description 2
- 229920001436 collagen Polymers 0.000 abstract description 2
- 238000002347 injection Methods 0.000 abstract description 2
- 239000007924 injection Substances 0.000 abstract description 2
- 238000012423 maintenance Methods 0.000 abstract description 2
- 230000003020 moisturizing effect Effects 0.000 abstract description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- 210000000695 crystalline len Anatomy 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 6
- 235000002673 Dioscorea communis Nutrition 0.000 description 6
- 241000544230 Dioscorea communis Species 0.000 description 6
- 208000035753 Periorbital contusion Diseases 0.000 description 6
- 229960005323 phenoxyethanol Drugs 0.000 description 6
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- -1 hydroxyl Benzoic ether Chemical compound 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 3
- 241000208680 Hamamelis mollis Species 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 229940118846 witch hazel Drugs 0.000 description 3
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 238000005260 corrosion Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 229940083542 sodium Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- FDHNLHLOJLLXDH-JIYHLSBYSA-N (e)-3-(3-hydroxy-4-methoxyphenyl)-1-[2-hydroxy-6-methoxy-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxyphenyl]prop-2-en-1-one Chemical compound C1=C(O)C(OC)=CC=C1\C=C\C(=O)C(C(=C1)OC)=C(O)C=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 FDHNLHLOJLLXDH-JIYHLSBYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 244000276331 Citrus maxima Species 0.000 description 1
- 235000001759 Citrus maxima Nutrition 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000256113 Culicidae Species 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 206010052139 Eye oedema Diseases 0.000 description 1
- 229920000855 Fucoidan Polymers 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 241000227647 Fucus vesiculosus Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 241000142952 Hamamelidaceae Species 0.000 description 1
- SHZGCJCMOBCMKK-PQMKYFCFSA-N L-Fucose Natural products C[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-PQMKYFCFSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 241000195474 Sargassum Species 0.000 description 1
- 241001486234 Sciota Species 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000737023 Zebrasoma flavescens Species 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000002804 anti-anaphylactic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 229940076640 hesperidin methylchalcone Drugs 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
Abstract
本发明属于医用美容护肤技术领域，具体涉及一种可淡化黑眼圈、祛眼袋和眼纹的组合物。所述组合物由以下质量百分比的组分组成：生物糖胶‑15.0‑6.0％；透明质酸钠0.01‑0.03％；北美金缕梅提取物2.0‑5.0％；尿囊素0.3‑0.5％；橙皮苷甲基查尔酮0.5‑0.8％％；螯合剂0.1‑0.2％；酒石酸2.0‑3.0％；1、2‑己二醇1.0‑3.0％；防腐剂0.1‑0.2％；聚丙烯酸钠0.1‑0.2％；甘油2.0‑4.0％；蒸馏水：余量。所述组合物具有补水、修护干纹、淡化黑眼圈、收敛眼袋的作用；有效成分可深入眼部肌底呵护眼部肌肤；所采用的防腐剂对人体安全，消费者可放心使用。
Description
技术领域
本发明属于医用美容护肤技术领域，具体涉及一种可淡化黑眼圈、祛眼袋和眼纹的组合物。
背景技术
随着人年龄的增长，新陈代谢的能力会慢慢减弱，皮肤会逐渐失去弹性。眼睛一直被称为灵魂之窗，而眼部肌肤比脸部其他部位的肌肤要薄很多，更容易受到外界的伤害，所以衰老特征会先在眼部体现。眼部皮下的疏松结缔组织丰富，且柔软而富有弹性，疏松结缔组织的纤维结构中分布着极为丰富的毛细血管和神经末梢，这些毛细血管的管壁非常薄，并且具有一定的渗透性，所以疏松的结缔组织很容易充血、积水而形成血肿和水肿。眼部皮下几乎没有皮脂腺或者汗腺分布，而眼睛周围的细薄皮肤非常容易干燥缺水，且油脂的供给相对较少，进而导致眼部皮肤极容易衰老。
随着人们生活节奏的加快、生活压力的增大、生活环境的污染和手机电脑的普及，很多人经常会出现用眼过度的情况，眼睛十分疲劳，进而导致眼部产生皱纹、黑眼圈、眼袋等诸多问题。目前，市面上有很多眼部护理产品，受到了人们的喜爱，但眼部护理产品的质量参差不齐，比如，有的吸收不好，有的效果不明显，有些会出现过敏现象，更重要的是很多产品使用的防腐剂“对羟基苯甲酸酯”，根据目前的研究情况显示是有害的，引起了韩国化妆品业界对“对羟基苯甲酸酯”的重新审视。
因此，研发出一种既能有效对抗面部或眼部皮肤问题，又不使用有毒有害的防腐剂的眼膜，对人体安全负责的产品是符合当下消费者强烈需求的。
发明内容
有鉴于此，本发明的目的之一在于提供一种可淡化黑眼圈、祛眼袋和眼纹的组合物，所述组合物淡化黑眼圈、祛眼袋和眼纹的效果显著，且没有加入有害的防腐剂“对羟基苯甲酸酯”。
为实现上述目的，本发明采用以下方案：
所述可淡化黑眼圈、祛眼袋和眼纹的组合物由以下质量百分比的组分组成：
生物糖胶-1 5.0-6.0％；透明质酸钠0.01-0.03％；北美金缕梅提取物2.0-5.0％；尿囊素0.3-0.5％；橙皮苷甲基查尔酮0.5-0.8％％；螯合剂0.1-0.2％；酒石酸2.0-3.0％；1、2-己二醇1.0-3.0％；防腐剂0.1-0.2％；聚丙烯酸钠0.1-0.2％；甘油2.0-4.0％；蒸馏水：余量。
优选的，生物糖胶-1 5.2-6.0％；透明质酸钠0.02-0.03％；北美金缕梅提取物3.0-5.0％；尿囊素0.4-0.5％；橙皮苷甲基查尔酮0.6-0.8％；螯合剂0.15-0.2％；酒石酸2.2-3.0％；1、2-己二醇2.0-3.0％；防腐剂0.15-2.0％；聚丙烯酸钠0.15-2.0％；甘油3.0-4.0％；蒸馏水：余量。
更优选的，生物糖胶-1 5.5％；透明质酸钠0.02％；北美金缕梅提取物4.0％；尿囊素0.5％；橙皮苷甲基查尔酮0.7％；螯合剂0.15％；酒石酸2.5％；1、2-己二醇2.5％；防腐剂0.15％；聚丙烯酸钠0.15％；甘油3.5％；蒸馏水：余量。
生物糖胶-1(LC-1)是一种源自于中国渤海海域的生物多糖，因其分子中存在大量的岩藻糖(L-fucose)通常称为岩藻聚糖“Fucoidan”。主要存在于墨角藻、泡叶藻、裙带菜、羊栖菜、海蕴、厚叶解曼藻、海带等多种褐藻中。传统上，岩藻聚糖一直用于健康食品、药品原料，具有抗凝血、降血脂、抗慢性肾衰、抗肿瘤、抗病毒、促进组织再生、抑制胃溃疡、增强机体免疫机能等多种生理活性，是化妆品行业中一种新型的保湿剂、祛皱剂、肌肤修复剂和肤感调节剂。产品功效：长效的保湿剂，肌肤极度润泽，缓解肌肤细纹和皱纹；卓越的生物成膜剂，形成生物弹性膜，迅速起到舒缓抗过敏的作用；在不增加粘度情况下，提升细腻和柔软肤感，细腻柔软予产品轻快愉悦感。
透明质酸钠是人体内一种固有的成分,是一种葡聚糖醛酸，没有种属特异性，它广泛存在于胎盘,羊水,晶状体,关节软骨,皮肤真皮层等组织；器官中它分布在细胞质,细胞间质中，对其中所含的细胞和细胞器官本身起润滑与滋养作用，同时提供细胞代谢的微环境。
北美金缕梅，又名维吉尼亚金缕梅、弗尼吉亚金缕梅，是木兰纲、金缕梅科、金缕梅属的一种落叶灌木。原产于北美洲东部，由加拿大的新斯科舍省向西至美国的明尼苏达州，向南至佛罗里达州中部与得克萨斯州东部。蒸馏出来的花露水(hydrosol)可以用来保养皮肤，它是一种很强的抗氧化剂及收敛剂，用来治疗青春痘时非常有效。它也被推荐用来治疗干癣、湿疹、皮肤裂伤或起水泡、蚊虫叮咬、静脉曲张和痔疮等病症，对于皮肤割伤、擦伤及晒伤也有疗效。
总结来说，北美金缕梅提取物内含单宁质多种如Ellagtannin和Hamamlitannin可以调节皮脂分泌，具保湿及嫩白作用；促进淋巴血液循环，专门克服眼部浮肿和黑眼圈；具有镇静、安抚的效果，对龟裂、晒伤、粉刺有改善效果；可有效帮助肌肤夜间再生能力；去除眼袋，放松以及缓和对于油性肌肤和过敏性肌肤都有很优异的效果；有舒缓、收敛、抗菌的效果。因有收敛控油、杀菌的显著疗效，对于青春期少年或是出游状况较严重的皮肤，是不二选择。
尿囊素：由于尿囊素是一种两性化合物，能结合多种物质形成复盐，具有避光、杀菌防腐、止痛、抗氧化作用，能使皮肤保持水份，滋润和柔软，是美容美发等化妆品的特效添加剂，广泛用于雀斑霜、粉刺液、香波、香皂、牙膏、刮脸洗剂、护发剂、收敛剂、抗汗除臭洗剂等的添加剂。添加尿囊素的化妆品具有保护组织、亲水、吸水和防止水分散发等作用；添加尿囊素的发乳、发膏、洗发露，对头发有保护作用，可使头发不分叉、不断发；添加尿囊素的唇膏、面霜能使皮肤、嘴唇柔软且富有弹性，并有美丽的光泽。尿囊素促进组织生长，细胞新陈代谢，软化角质层蛋白。
橙皮苷甲基查尔酮(Hesperidin Methyl Chalcone)是一种橙皮苷类黄酮的衍生物，存在于柑橘类水果中，如橙子和柚子，常用于减轻眼底的黑眼圈。有一项研究表明，它可以降低毛细血管的过滤速度，减少接近皮肤表面的毛细血管的血流量，意味着可以减轻眼底的黑眼圈。它还被认为可以防止眼睛下方的静脉渗漏，防止皮肤表面下血液渗漏导致的暗蓝色调。
橙皮苷甲基查尔酮还被认为可以支持和保护血管系统的完整性，尤其是毛细血管和静脉。它还被证明可以通过增强血管韧性帮助强化毛细血管，降低毛细血管的渗透性，使血管更容易扩张。
进一步，所述螯合剂为EDTA二钠、EDTA-四钠和乙二胺。
优选的，所述螯合剂为EDTA二钠。
进一步，所述防腐剂为氯苯甘醚、苯氧乙醇。
有研究表明对羟基苯甲酸酯是为了防止化妆品的腐败,所使用的化学防腐剂。一位皮肤科专家表示,“对羟基苯甲酸酯成为接触性皮炎与皮肤过敏的原因,是内分泌障碍物质,所以在化妆品中逐渐的退出"。在韩国內持续上市的化妆品都排除对羟基苯甲酸酯,即使在化妆品中有少量的有害成分都不愿购买,这样的消费者趋势起了很大的作用。而氯苯甘醚以合成药品时使用的氯苯甘醚作为防腐剂,使用化妆品时,安全性大幅的提升。因此，考虑到安全性，所述组合物采用氯苯甘醚、苯氧乙醇作为防腐剂。
本发明的目的之二在于提供一种所述可淡化黑眼圈、祛眼袋和眼纹的组合物的一种应用。
为实现上述目的，本发明采用以下方案：
所述的可淡化黑眼圈、祛眼袋和眼纹的组合物在制备面部或眼部护理产品中的应用。
进一步，所述面部护理产品包括面霜、面膜和面部水乳产品。
进一步，所述眼部护理产品为眼膜或眼部凝胶。
进一步，所述可淡化黑眼圈、祛眼袋和眼纹的组合物在眼膜中的添加量为40-50％。
本发明的有益效果在于：
1)本发明提供的可淡化黑眼圈、祛眼袋和眼纹的组合物具有补水、修护干纹、淡化黑眼圈、收敛眼袋的作用；有效成分可深入眼部肌底呵护眼部肌肤；
2)本发明提供的可淡化黑眼圈、祛眼袋和眼纹的组合物所采用的防腐剂对人体安全，消费者可放心使用。
具体实施方式
所举实施例是为了更好地对本发明进行说明，但并不是本发明的内容仅局限于所举实施例。所以熟悉本领域的技术人员根据上述发明内容对实施方案进行非本质的改进和调整，仍属于本发明的保护范围。
实施例1可淡化黑眼圈、祛眼袋和眼纹的组合物
生物糖胶-1 5.0-6.0％；透明质酸钠0.01-0.03％；北美金缕梅提取物2.0-5.0％；尿囊素0.3-0.5％；橙皮苷甲基查尔酮0.5-0.8％％；EDTA二钠0.1-0.2％；酒石酸2.0-3.0％；1、2-己二醇1.0-3.0％；防腐剂(苯甘醚和苯氧乙醇)0.1-0.2％；聚丙烯酸钠0.1-0.2％；甘油2.0-4.0％；蒸馏水：余量。
实施例2可淡化黑眼圈、祛眼袋和眼纹的组合物
生物糖胶-1 5.2-6.0％；透明质酸钠0.02-0.03％；北美金缕梅提取物3.0-5.0％；尿囊素0.4-0.5％；橙皮苷甲基查尔酮0.6-0.8％；EDTA二钠0.15-0.2％；酒石酸2.2-3.0％；1、2-己二醇2.0-3.0％；防腐剂(苯甘醚和苯氧乙醇)0.15-2.0％；聚丙烯酸钠0.15-2.0％；甘油3.0-4.0％；蒸馏水：余量。
实施例3可淡化黑眼圈、祛眼袋和眼纹的组合物
生物糖胶-1 5.5％；透明质酸钠0.02％；北美金缕梅提取物4.0％；尿囊素0.5％；橙皮苷甲基查尔酮0.7％；EDTA二钠0.15％；酒石酸2.5％；1、2-己二醇2.5％；防腐剂(苯甘醚和苯氧乙醇)0.15％；聚丙烯酸钠0.15％；甘油3.5％；蒸馏水：余量。
实施例4可淡化黑眼圈、祛眼袋和眼纹的眼部凝胶
取实施例1-3各质量百分比的组分，向所述配方量的生物糖胶-1中加入至少2倍的蒸馏水，使生物糖胶-1溶解，然后再向生物糖胶-1溶解液中加入尿囊素、甘油并混合均匀后，加入透明质酸钠、北美金缕梅提取物、橙皮苷甲基查尔酮、酒石酸、1、2-己二醇、聚丙烯酸钠、EDTA二钠、氯苯甘醚和苯氧乙醇，混合均匀，再加入余量蒸馏水搅拌静置形成眼部凝胶。
实施例5可淡化黑眼圈、祛眼袋和眼纹的眼膜和面膜
取实施例4的眼部凝胶，通过碾压复合涂布成型，将混合搅拌均匀的凝胶利用下料装置涂布于水刺布，然后用聚乙烯膜进行复合，达到涂布成型的目的，得到最终的眼膜和面膜，凝胶占眼膜重量的40-50％。
实施例6眼膜的使用评价
采取100个经常加班、熬夜以及有眼部细纹的人进行使用前后对比，可以观察到使用了眼膜后的黑眼圈明显淡化、细纹减少，眼袋变小。
最后说明的是，以上实施例仅用以说明本发明的技术方案而非限制，尽管参照较佳实施例对本发明进行了详细说明，本领域的普通技术人员应当理解，可以对本发明的技术方案进行修改或者等同替换，而不脱离本发明技术方案的宗旨和范围，其均应涵盖在本发明的权利要求范围当中。
Claims (9)
1.一种可淡化黑眼圈、祛眼袋和眼纹的组合物，其特征在于，由以下质量百分比的组分组成：
生物糖胶-1 5.0-6.0％；透明质酸钠0.01-0.03％；北美金缕梅提取物2.0-5.0％；尿囊素0.3-0.5％；橙皮苷甲基查尔酮0.5-0.8％％；螯合剂0.1-0.2％；酒石酸2.0-3.0％；1、2-己二醇1.0-3.0％；防腐剂0.1-0.2％；聚丙烯酸钠0.1-0.2％；甘油2.0-4.0％；蒸馏水：余量。
2.根据权利要求1所述的组合物，其特征在于，由以下质量百分比的组分组成：
生物糖胶-1 5.2-6.0％；透明质酸钠0.02-0.03％；北美金缕梅提取物3.0-5.0％；尿囊素0.4-0.5％；橙皮苷甲基查尔酮0.6-0.8％；螯合剂0.15-0.2％；酒石酸2.2-3.0％；1、2-己二醇2.0-3.0％；防腐剂0.15-2.0％；聚丙烯酸钠0.15-2.0％；甘油3.0-4.0％；蒸馏水：余量。
3.根据权利要求2所述的组合物，其特征在于，由以下质量百分比的组分组成：
生物糖胶-1 5.5％；透明质酸钠0.02％；北美金缕梅提取物4.0％；尿囊素0.5％；橙皮苷甲基查尔酮0.7％；螯合剂0.15％；酒石酸2.5％；1、2-己二醇2.5％；防腐剂0.15％；聚丙烯酸钠0.15％；甘油3.5％；蒸馏水：余量。
4.根据权利要求1-3任一项所述的组合物，其特征在于，所述螯合剂为EDTA二钠。
5.根据权利要求1-3任一项所述的组合物，其特征在于，所述防腐剂为氯苯甘醚、苯氧乙醇。
6.权利要求1-5任一项所述的可淡化黑眼圈、祛眼袋和眼纹的组合物在制备面部或眼部护理产品中的应用。
7.根据权利要求6所述的应用，其特征在于，所述面部护理产品包括面霜、面膜和面部水乳产品。
8.根据权利要求6所述的应用，其特征在于，所述眼部护理产品为眼膜或眼部凝胶。
9.根据权利要求8所述的应用，其特征在于，所述可淡化黑眼圈、祛眼袋和眼纹的组合物在眼膜中的添加量为40-50％。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910449400.3A CN110063916A (zh) | 2019-05-28 | 2019-05-28 | 可淡化黑眼圈、祛眼袋和眼纹的组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910449400.3A CN110063916A (zh) | 2019-05-28 | 2019-05-28 | 可淡化黑眼圈、祛眼袋和眼纹的组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110063916A true CN110063916A (zh) | 2019-07-30 |
Family
ID=67371789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910449400.3A Pending CN110063916A (zh) | 2019-05-28 | 2019-05-28 | 可淡化黑眼圈、祛眼袋和眼纹的组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110063916A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110464658A (zh) * | 2019-08-07 | 2019-11-19 | 广州艾蓓生物科技有限公司 | 一种多效眼部冻干膜及蒸汽眼罩 |
| CN110585030A (zh) * | 2019-09-27 | 2019-12-20 | 广州香枝化妆品有限公司 | 一种高分子凝胶祛皱眼膜及其制备方法 |
| CN111743833A (zh) * | 2020-06-30 | 2020-10-09 | 广州市科能化妆品科研有限公司 | 一种祛黑眼圈祛眼袋组合物及其制备方法和应用 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104083317A (zh) * | 2014-06-27 | 2014-10-08 | 郑州市嘉蓓丽生物科技有限公司 | 一种白芽茶眼部护理霜及其制备方法 |
| CN108066276A (zh) * | 2018-02-01 | 2018-05-25 | 伯仕利生物科技发展（盐城）有限公司 | 一种含复合干细胞因子眼啫喱的制备方法 |
| CN108888562A (zh) * | 2018-08-30 | 2018-11-27 | 广东长昊药业股份有限公司 | 一种眼膜及其制备方法 |
| CN109568227A (zh) * | 2018-12-05 | 2019-04-05 | 中山市美太保健制品有限公司 | 一种祛黑眼圈凝露及其制备方法 |
-
2019
- 2019-05-28 CN CN201910449400.3A patent/CN110063916A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104083317A (zh) * | 2014-06-27 | 2014-10-08 | 郑州市嘉蓓丽生物科技有限公司 | 一种白芽茶眼部护理霜及其制备方法 |
| CN108066276A (zh) * | 2018-02-01 | 2018-05-25 | 伯仕利生物科技发展（盐城）有限公司 | 一种含复合干细胞因子眼啫喱的制备方法 |
| CN108888562A (zh) * | 2018-08-30 | 2018-11-27 | 广东长昊药业股份有限公司 | 一种眼膜及其制备方法 |
| CN109568227A (zh) * | 2018-12-05 | 2019-04-05 | 中山市美太保健制品有限公司 | 一种祛黑眼圈凝露及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 5号网-XWEIYI: "菲洛嘉眼霜适合什么肤质?菲洛嘉眼霜适合年龄", 《HTTP://WWW.5H.COM/MR/28108.HTML》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110464658A (zh) * | 2019-08-07 | 2019-11-19 | 广州艾蓓生物科技有限公司 | 一种多效眼部冻干膜及蒸汽眼罩 |
| CN110585030A (zh) * | 2019-09-27 | 2019-12-20 | 广州香枝化妆品有限公司 | 一种高分子凝胶祛皱眼膜及其制备方法 |
| CN111743833A (zh) * | 2020-06-30 | 2020-10-09 | 广州市科能化妆品科研有限公司 | 一种祛黑眼圈祛眼袋组合物及其制备方法和应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106580798B (zh) | 一种全效眼霜及制备方法 | |
| CN106137786B (zh) | 一种透明质酸抗衰组合物及其制备方法和应用 | |
| CN106137906A (zh) | 一种植物精粹修护面膜精华液 | |
| CN104188885A (zh) | 一种滋润保湿型紫草润唇膏及其制备方法 | |
| CN110063916A (zh) | 可淡化黑眼圈、祛眼袋和眼纹的组合物 | |
| CN113117137A (zh) | 一种含有重组人源胶原蛋白的医用敷料及制备方法 | |
| CN107714504A (zh) | 一种同人源胶原蛋白组合物及其在化妆品中应用 | |
| CN110051602B (zh) | 一种润肤保湿修复乳液及其制备方法 | |
| CN110585030A (zh) | 一种高分子凝胶祛皱眼膜及其制备方法 | |
| CN106074220B (zh) | 一种纳米脂质体面膜及其制备方法 | |
| CN107303253A (zh) | 一种用于受损肌肤的修复剂及其制备方法 | |
| CN107296764A (zh) | 膏霜及其制备方法 | |
| CN105434258A (zh) | 余甘子活肤润肤霜 | |
| KR20090041886A (ko) | 식물성 3중 보습 성분 및 이를 포함하는 스킨 케어 조성물 | |
| CN110302081A (zh) | 一种双重玻尿酸原液及其制备方法 | |
| CN106265472A (zh) | 清润活力保湿乳及其制备方法 | |
| CN105362166A (zh) | 含光果甘草的美白化妆品 | |
| CN106727251A (zh) | 一种天然蜂毒凝胶霜及其制备工艺 | |
| CN110101585A (zh) | 一种3d网状交错眼膜及其制备方法 | |
| CN109481323A (zh) | 一种芦荟原汁保湿油及其制备方法 | |
| CN115429738A (zh) | 一种祛痘修护焕活精华液及其制备方法 | |
| CN107468605A (zh) | 一种紫草绿茶清凉爽身粉 | |
| CN105250172A (zh) | 金缕梅按摩香脂 | |
| JP2006199620A (ja) | ケイ素化合物を応用した化粧品及びその製造方法 | |
| CN110721119A (zh) | 一种化妆品原液及其制备方法和应用以及一种面霜 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190730 |